Reconstruction of the Epidemic History of the Beijing Genotype of Mycobacterium tuberculosis in Russia and Former Soviet Countries Using Spoligotyping

Size: px
Start display at page:

Download "Reconstruction of the Epidemic History of the Beijing Genotype of Mycobacterium tuberculosis in Russia and Former Soviet Countries Using Spoligotyping"

Transcription

1 ISSN , Molecular Genetics, Microbiology and Virology, 011, Vol. 6, No. 3, pp Allerton Press, Inc., 011. Original Russian Text V.V. Sinkov, E.D. Savilov, O.B. Ogarkov, 011, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 011, No. 3, pp EXPERIMENTAL WORKS Reconstruction of the Epidemic History of the Beijing Genotype of Mycobacterium tuberculosis in Russia and Former Soviet Countries Using Spoligotyping V. V. Sinkov a, E. D. Savilov b, c, and O. B. Ogarkov b, d a Irkutsk Regional Diagnostic Center, Irkutsk, Russia b Institute of Epidemiology and Microbiology, Siberian Branch, Russian Academy of Medical Sciences, Irkutsk, Russia c Irkutsk Institute for Medical Advanced Studies, Irkutsk, Russia d Irkutsk TB-prevention Dispensary, Irkutsk, Russia Received January 14, 011 All known genotypes (395 spoligoprofiles of M. tuberculosis) were selected using the SITVIT database in nine countries, including countries of the former Soviet Union: Russia, Latvia, Estonia, Poland, Finland, Italy, Portugal, Japan, and Vietnam. The programs SpolTools and DESTUS were used to construct consensus networks to identify the epidemic genotypes of M. tuberculosis in the studied countries. In Russia, Latvia, and Estonia, the Beijing strain was determined as the main epidemic genotype. In Finland, Poland, Portugal, and Italy, all epidemic genotypes belonged to other families. The hypothesis on the explosive nature of the spreading of the Beijing genotype of M. tuberculosis was put forward for Russia and other former Soviet countries in the 0th century. The basic idea of the hypothesis was that the pattern of dissemination of the Beijing genotype occurred at the CER (Chinese Eastern Railway), in the Gulag, and in the civilian society of Soviet Union. The Beijing genotype of M. tuberculosis affected Russian builders of the CER during the end the 19th and early 0th centuries. With the repression of CER builders in the Soviet Union, the Beijing genotype was spread among Gulag prisoners; after 1953, it had spread throughout the civilian society of the entire country. The distribution of epidemic genotypes of M. tuberculosis in the studied countries was interpreted as evidence of the suggested hypothesis. Keywords: spoligotyping, M. tuberculosis DOI: /S INTRODUCTION Today, tuberculosis remains one of the most challenging problems of practical healthcare worldwide. 1 According to WHO data, more than two billion people, i.e., one-third of the Earth s population, are infected with Mycobacterium tuberculosis, and one in ten infected people experience the tuberculosis disease during their lifetime [9]. In 009, 9.4 million cases of tuberculosis were registered in the world [9], with an average frequency of 139 disease cases per people [9, 9]. In 008, 1.8 million people died of tuberculosis, including HIV-infected ones, which is an average of 4500 deaths per day [9]. Moreover, the incidence rate has been shown to be increasing not only in developing countries, but also in Western Europe and United States. Russia, where a marked rise in all epidemiological markers of tuberculosis has been observed in recent decades, is not an exclusion [1]. Indeed, in 007, the incidence rate of tuberculosis among the adult population of Russia was 8.6 per people, with a lethality rate of 18.1 per people, which accounts for 85% of lethal cases of all infectious and parasitic diseases [7]. In comparison with 1990s (the beginning of the increase in the incidence rate), the lethality of tuberculosis has increased by.6 times [7]. Tuberculosis is characterized by an irregular geographical distribution. Minimal incidence rates have been observed in North and South America (3%) and Europe (5%), while maximal incidence rates have been observed in southeast Asia (55%) and Africa (31%) [5]. Presently, the distribution of tuberculosis is characterized as pandemic [14], the most important aetiological agent of which is genetically a similar group of strains called the Beijing genotype [8]. It should be noted that in Russia this subfamily prevails over all registered genotypes [, 3, 8, 11, 19, 6], making Russia considerably different from other European states [17]. However, it is important to note that newly formed European states founded on the basis of former republics of the USSR (Latvia, Lithuania, and Estonia) demonstrate a situation similar to that in Russia [16, 0, 7]. The genetic diversity of M. tuberculosis has been formed as a result of population migrations. Evidently, the Beijing genotype of M. tuberculosis occurred in northern China more than 000 years ago and pene- 10

2 RECONSTRUCTION OF THE EPIDEMIC HISTORY OF THE BEIJING GENOTYPE 11 trated to other regions via population migrations from southeast Asia [6]. I. Mokrousov et al. suggest that the predominance of the Beijing genotype in Russia originates from the medieval epoch and is connected with the Mongol Tatar invasion []. This was the time when contact between Slavs and Europeans with the Beijing genotype would have first taken place. However, this hypothesis fails to explain the phenomenon of the high similarity between M. tuberculosis genotypes in Russia and the Baltic states, which are former Soviet Union republics [16, 0, 7]. It is also impossible to explain the differences in this genotype distribution in the former Soviet states in comparison with other European states, including former Soviet states, within the framework of the medieval model [6, 8, 16, 19, 0, 6, 7]. Therefore, it seems that the scenario of the Beijing genotype s distribution must be different. It may be hypothesized that the distribution of the Beijing genotype of M. tuberculosis reached its modern level in Russia and the Baltic states (Latvia, Lithuania and Estonia) in a relatively short period of the USSR, whereas in neighboring states the distribution of the Beijing genotype remained the same, possibly at medieval levels. In order to verify this hypothesis, a model of evolutionary relationships among the strains of M. tuberculosis in the studied states was composed, and epidemiologically important genotypes were identified. Use of this model allowed us to obtain statistically significant data about the differences between the most important genotypes of tuberculosis etiological factors circulating in Russia, the Baltic states, and other European states. The present study was aimed at the formulation of the Beijing genotype s distribution scenario in the USSR region in the 0th century on the basis of molecular modeling results for the processes of occurrence of epidemiologically important M. tuberculosis genotypes in the studied states. MATERIALS AND METHODS Known genotypes of M. tuberculosis obtained by spoligotyping were used for the study. Spolygotyping profiles were obtained from the online database SITVIT [1]. In total, 395 genotypes (906 unique variants), which were isolated from the patients from Russia, Latvia, Estonia, Poland, Finland, Italy, Portugal, Japan, and Vietnam, were studied. The information about each spoligotype was presented as a numerical sequence of 43 numerals, where a deletion was marked as 0 and the absence of deletion was marked as 1. All spoligotypes were saved as.rsf files (rich spoligotype format) for further analysis with the Spol- Tool program [5]. A consensus spoligoforest network was composed on the basis of SpolTool spoligotypes [4]. The size of each cluster in the consensus network corresponded to the number of isolates of identical spoligotype. Signs between the clusters of the pictures show evolutionary interconnections between spoligo- States, number of strains and spoligotypes used in the study State Number of strains Number of spoligotypes Russia Finland Poland Latvia Estonia Portugal Italy Japan Vietnam Tota types and the calculated direction of mutation event ancestors to descendants. To ensure the correctness of the choice of an epidemiologically important genotype, data verification algorithms aimed at controling for the absence of false-positive interconnections with multiple data comparison were used (Bonferroni rule) with the DESTUS (Detecting Emerging Strains of Tuberculosis Using Spoligotypes) program [5]. The stability of spoligotrees was assessed using the Benjamini Hochberg, Storey, and Dunn Sidak algorithms, which calculate false discovery rate (FDR). Genotypes which demonstrated values of p < 0.01 in the sequential analysis with all three algorithms were considered epidemiologically significant. The relationships of epidemiologically significant genotypes to the known M. tuberculosis subfamilies were estimated using the spoligotype database SpolDB4 in accordance with their ST numbers [15]. RESULTS AND DISCUSSION In order to perform a comparative assessment, countries which were both historically and geographically related to Russia (Finland, Poland, Latvia, and Estonia) and were well-represented in the SpolDB4 database [15] were chosen. The fact that Lithuania was omitted is due to its poor representation in the SpolDB4 database. The other group included contrast countries which were poorly connected with Russia both historically and geographically. European states (Portugal and Spain) where the Beijing genotype is insignificantly distributed, as well as Asian states (Japan and Vietnam) where it dominates, were also chosen [13, 18]. The list of countries studied, number of M. tuberculosis strains, and the number of spoligotypes used in the study are shown in the table. States where a single genotype obviously dominates were not chosen for the study. The main parameters for a spoligotree analysis were cluster sizes and the number of ancestors [3]. For example, large clusters with numerous descendants were thought to evidence the ancientness of a genotype. Such a spoligotype could MOLECULAR GENETICS, MICROBIOLOGY AND VIROLOGY Vol. 6 No

3 1 SINKOV et al. Rank Spoligotype Subfamily p log(p) Spoligoforest Russia 1 Beijing 9.913e ST53 T1.7714e ST5 LAM e ST4 LAM ST54 T5_RUS e H e ST6 H e ST35 H4 1.13e Estonia 1 Beijing e (467) ST8 (8) ST3134 (18) (50) ST54 (50) ST53 (67) ST35 (18) ST4 (5) ST5 (5) Latvia 1 Beijing.1067e (75) Japan 1 Beijing.308e (169) Vietnam 1 39 EA14_VN M 1.688Be Beijing (181) (387) Note: Here and in Fig., the genotype rank shows the calculated epidemic significance of a genotype in comparison with that of other genotypes that circulate in a country; number in the SpolDB4 database [15]; subfamily name [15]; p value calculated by DESTUS program [5]; logarithms calculated with the same program, which provide the basis for assessment of epidemic significance (rank) of a genotype; spoligoforest of epidemiologically significant genotypes for each state. Fig. 1 States where the Beijing genotype () was shown to be epidemiologically significant. have been distributed in a population for a long period and should have had sufficient time to accumulate a good deal of mutations. However, from an epidemiological point of view, genotypes which can be distributed in a population faster than the natural process of mutation accumulation are of much more interest. These genotypes are characterized by larger cluster sizes and a minimal number of descendants and must be considered epidemiologically significant [3]. As a result of modeling, a consensus spoligoforest network which, after performing the Bonferroni test, allowed statistically significant isolation of the epidemic genotype [5] was obtained for each country [4]. Data on the full structure of the spoligotype consensus network for each country are not shown in the paper due to their bulkiness. The described modeling revealed epidemiologically significant genotypes with the confidence level p < The revealed genotypes are shown in Figs. 1 and. Connections between the clusters in Fig. 1 and show the presence of a final mutation step number between epidemic genotypes, which allows the Spol- MOLECULAR GENETICS, MICROBIOLOGY AND VIROLOGY Vol. 6 No

4 RECONSTRUCTION OF THE EPIDEMIC HISTORY OF THE BEIJING GENOTYPE 13 Rank Spoligotype Subfamily p log(p) Spoligoforest Finland 1 ST49 H e ST47 H e ST53 T e ST50 H e ST6 H4 1.94e LAM9 4.95e (181) (387) Poland H1.638e ST891 LAM e (16) ST891 (1) Portugal 1 ST0 LAM1.88e ST4 LAM e ST0 (49) ST4 (44) Italy 1 ST33 LAM3.3044e ST53 T1.4319e CAS1-DELHI e ST50 H e ST6 H e ST73 T-T e ST53 (54) 346 (14) ST33 (16) ST50 (30) ST73 (11) ST6 (14) Fig.. States from the comparison group, where the Beijing genotype was not shown to be epidemiologically significant. Tool program to calculate the virtual ancestor of epidemic genotypes; in contrast, the absence of these connections indicates significant genetic differences between these genotypes. Figure 1 shows countries (except Vietnam) where the Beijing genotype () is epidemiologically significant; i.e., it demonstrates the first rank of epidemic significance. Figure shows the countries of the comparison group. The Beijing genotype was shown to be the only epidemiologically significant genotype for the Baltic States (Estonia had 119 strains and Latvia had 140 strains) (Fig. 1). At the same time, the neighboring countries of Finland and Poland demonstrated a totally different spectrum of epidemic genotypes, in which strains of LAM, T, and Haarlem prevailed (Fig. ). The Russian epidemic genotype profile (Fig. 1) demonstrates both European (LAM and T) and Asian (Beijing) traits. The Haarlem 4 subfamily, which is more correctly called Ural, was also found among Russian epidemic genotypes [8, 19]. Apparently, this group of closely related genotypes [8] (Fig. 1 shows them all connected with each other) has different origins than other epidemic genotypes shown in Figs. 1 and. Therefore, the results of modeling of the formation processes of genotypes of M. tuberculosis strains from three states of the former USSR (Russia, Estonia, and Latvia), two neighboring states (Finland and Poland), and two remote European states (Portugal and Italy) may suggest that the Beijing genotypes identified in Russia, Estonia, and Latvia originate from a single source. Moreover, the absence of other epidemic genotypes in the studied Baltic states allows us to hypothesize relatively recent epidemics induced by the spoligotype. It goes without saying that it is not possi- MOLECULAR GENETICS, MICROBIOLOGY AND VIROLOGY Vol. 6 No

5 14 SINKOV et al. ble to exclude the probability that the Beijing genotype was presented earlier in the Russian Empire, as for example in the comparison states [16, 17, 0, 7]. However, the Beijing genotype () distribution pattern in Russia and the Baltic states suggests a single moment and an explosive distribution of this subfamily s strains. The scenario for such an epidemiological process could be as follows: the Beijing genotype is endemic to China and neighboring countries [14], and its history dates back several centuries [6]. However, contacts between the Russian Empire and China were very limited during this period, and only in the 0th century did a small Russian-speaking society form in Chinese territory due to the building of the China Eastern Railway and the development of neighboring lands [1]. Later, in the period of cooling of relations between the USSR and China, workers of the China Eastern Railway were forced to return to the USSR, which coincided with the period of mass repressions [1]. Tens of thousands of repatriates were jailed in correctional labor colonies, which led to the wide distribution of Beijing subfamily tuberculosis strains first among Gulag prisoners, and later, after the amnesty in 1953, in the civilian society of the Soviet Union. Within the framework of the unified state (USSR) and, more importantly, the unified penitentiary system, the soligotype was distributed throughout the entire territory of the Soviet Union, including the Baltic states. At the same time, in the countries of the Eastern Bloc, the profile of epidemic strains of tuberculosis did not change significantly or changed in accordance with the principles observed in other European states in the 0th century. These observations were even more surprising in light of the fact that both Finland and Poland were either totally or partially integrated into the Russian Empire: Finland from 1809 to 1917 [10] and the Polish Kingdom (with a population of.7 million) from 1815 to 1915 [4]. Similarly, both Baltic states studied were integrated into the Russian Empire: Estonia from 171 to 1918 and Latvia from 1796 to 190 as a part of the Province of Courland [4]. Therefore, the middle of the 0th century is considered to be the most likely date for the massive distribution of the spoligotype in the Baltic states. Evi- dently, the possibility of distribution of tuberculosis strains across the borders of states under the regular conditions of civilian society is much smaller than is traditionally supposed. It is suggested that even the relatively short historical period of the unified penitentiary system drastically affected the process of distribution of tuberculosis strains of the Beijing subfamily. It should be noted as a conclusion that the methods of molecular epidemiology are doubtlessly important for tuberculosis studies. The identification of epidemiologically important genotypes and the analysis of their structure in different countries and continents allow us to retrace the historical paths of epidemic distribution and identify the epicenters of highly active genotypes. This, in turn, provides the basis for antiepidemic and therapeutic approaches aimed against tuberculosis infection. REFERENCES 1. Ablazhei, N.N., Emigration from Russia (SSSR) to China and Reimmigration in the First Half of the XX Century, Extended Abstract of Doctoral (Histor.) Dissertation, Moscow, Balabanova, Ya.M., Nikolaevskii, V.V., and Raddi, M., Probl. Tub., 006, no., pp Baranov, A.A., Mar yandyshev, A.O., Markelov, Yu.M., et al., Ekol. Chel., 007, vol. 7, pp Bokhanov, A. and Gorinov, M., Istoriya Rossii s nachala XVIII do kontsa XIX veka (History of Russia from the Beginning of XVIII to the End of XIX Century), Sakharov, A.N., Ed., Moscow, Global naya bor ba s tuberkulezom (doklad) (Global Tuberculosis Control (Report)), WHO, Mokrousov, I.V., Genetic Diversity and Evolution of Mycobacterium tuberculosis, Extended Abstract of Doctoral (Biol.) Dissertation, St. Petersburg, On the Number of Tuberculosis Cases. Letter no. 01/ dated Federal Service on Surveillance of Consumer s Right Protection and Human Wellbeing, 008. URL: httr:// dosuments/letters/74/. 8. Ogarkov, O.B., Medvedeva, T.V., and Zozio, G., Mol. Med., 007, no., pp Onishchenko, G., Vestn. Ross. Akad. Med. Nauk, 008, no. 3, pp Osmo, Yu., Velikoe knyazhestvo Finlyandskoe (The Grand Duchy of Finland), Rumyantsev, A., Ed., Helsinki, Savilov, E.D., Sin kov, V.V., and Ogarkov, O.B., Epid. Infekts. Bol., 010, no. 4, pp Ftiziatriya. Natsional noe rukovodstvo (Phthisiology: National Guidance), Perel man, M.I., Ed., Moscow, Anh, D.D., Borgdor, M.W., Van, I.N., et al., Emerg. Infect. D, 000, vol. 6, no. 3, pp Bifani, P.J., Mathema, В., Kurepina, N.E., and Kreiswirth, B.N., Trends Microbiol., 00, vol. 10, no. 1, pp Brudey, K., Driscoll, J.R., Rigouts, L., et al., BMC Microbiol., 006, vol. 6, p Devaux, I., Kremer, K., Heersma, H., and Soolingen, D.V., Emerg. Infect. Dis., 009, vol. 15, no. 7, pp Harvard Medical School O. S. I. The Global Impact of Drug-Resistant Tuberculosis, Heymann, D.L., Ed., Boston, Iwamoto, T., Kekkaku, 009, vol. 84, no. 1, pp Kovalev, S.Y., Kamaev, E.Y., Kravchenko, M.A., et al., Int. J. Tuberc. Lung D, 005, vol. 9, no. 7, pp MOLECULAR GENETICS, MICROBIOLOGY AND VIROLOGY Vol. 6 No

6 RECONSTRUCTION OF THE EPIDEMIC HISTORY OF THE BEIJING GENOTYPE Kröner, A., Hoffner, S.E., Sillastu, H., et al., J. Clin. Microbiol., 001, vol. 39, no. 9, pp Liens, В., Sola, C., Brudey, K., and Rastogi, N., 6th Annu. Congr. Eur. Soc. Mycobacteria, Turkey, Istambul, June 6 9, Mokrousov, I., Ly, H.M., Often, T., et al., Genome Res., 005, vol. 15, pp Reyes, J.F., Francis, A.R., and Tanaka, M.M., BMC Bioinformatics, 008, vol. 9, p Tanaka, M.M. and Francis, A.R., Proc. Natl. Acad. Sci. USA, 006, no. 41, pp Tang, C., Reyes, J.F., Luciani, F., et al., Bioinformatics, 008, vol. 4, no. 0, pp Toungoussova, O.S., Sandven, P., Mariyandyshev, A.O., et al., J. Clin. Microbiol., 00, vol. 40, no. 6, pp Tracevska, Т., Jansone, I., Baumanis, V., et al., Int. J. Tuberc. Lung Dis., 003, vol. 7, no. 11, pp Van Soolingen, D., Qian, L., de Haas, P.E., et al., J. Clin. Microbiol., 1995, vol. 33, pp WHO Stop ТВ Partnership Update Tuberculosis Facts, 009. URL: tbfactsheet_009update_one_page.pdf SPELL: 1. healthcare,. spoligotype, 3. antiepidemic MOLECULAR GENETICS, MICROBIOLOGY AND VIROLOGY Vol. 6 No

DRUG-SENSITIVE AND RESIStant

DRUG-SENSITIVE AND RESIStant ORIGINAL CONTRIBUTION Drug-Resistant Tuberculosis, Clinical Virulence, and the Dominance of the Beijing Strain Family in Russia Francis Drobniewski, MD, PhD Yanina Balabanova, MD, PhD Vladyslav Nikolayevsky,

More information

Estimates for the mutation rates of spoligotypes and VNTR types of Mycobacterium tuberculosis

Estimates for the mutation rates of spoligotypes and VNTR types of Mycobacterium tuberculosis Estimates for the mutation rates of spoligotypes and VNTR types of Mycobacterium tuberculosis Josephine F. Reyes and Mark M. Tanaka November 30, 2009 1/21 Understanding diversity in bacterial pathogens

More information

High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India

High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India BRIEF REPORT High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India Deepak Almeida, 1 Camilla Rodrigues, 2 Tester

More information

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis

More information

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant

More information

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology

More information

Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis

Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management

More information

Drug-resistant Tuberculosis

Drug-resistant Tuberculosis page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of

More information

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium

More information

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,

More information

Summary. Primary care data. Week 49/2014. Season

Summary. Primary care data. Week 49/2014. Season Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations

More information

Drug-resistant Tuberculosis

Drug-resistant Tuberculosis page 1/15 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Level 2 - Details on Drug-resistant Tuberculosis 1. What is tuberculosis and why is it

More information

3.1 PHASE 2 OF THE GLOBAL PROJECT

3.1 PHASE 2 OF THE GLOBAL PROJECT RESULTS CHAPTER 3 3.1 PHASE 2 OF THE GLOBAL PROJECT (1996 1999) This new report of the Global Project provides data on anti-tuberculosis drug resistance from 58 geographical settings. Of these, 28 provided

More information

The Barents Tuberculosis Program. The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues

The Barents Tuberculosis Program. The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues The Barents Tuberculosis Program The Barents Euro-Arctic Council Joint Working Group on Health and Related Social Issues 1 CONTENTS Introduction... 4 General Information... 7 Epidemiological Situation

More information

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. The State of Cardiovascular Disease in the Kyrgyz Republic Ryskul B. Kydyralieva The National Center of Cardiology and Internal Medicine named after academician M.Mirrahimov at Ministry of Health of the

More information

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium

More information

Access to treatment and disease burden

Access to treatment and disease burden Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns,

Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, ORIGINAL ARTICLE BACTERIOLOGY Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, 2008 2011 P. W. Smit 1,2, M. Haanper a 2, P. Rantala 2,

More information

Influenza Update N 176

Influenza Update N 176 Update N 176 04 January 2013 Summary Reporting of influenza activity has been irregular in the past two weeks due to the holiday season in many countries. As a result, overall virus detections have dropped

More information

Guidance for Identifying Risk Factors for Mycobacterium tuberculosis (MTB) During Evaluation of Potential Living Kidney Donors

Guidance for Identifying Risk Factors for Mycobacterium tuberculosis (MTB) During Evaluation of Potential Living Kidney Donors Summary and Goals On November 13, 2012, the OPTN/UNOS Board of Directors approved a requirement that all potential living kidney donors undergo evaluation for infection with Mycobacterium tuberculosis

More information

The WHO END-TB Strategy

The WHO END-TB Strategy ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who

More information

Global, National, Regional

Global, National, Regional Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology

More information

At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia

At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia RESEARCH ARTICLE At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia Igor Mokrousov 1,2, Tatiana Otten 3, Thierry Zozio 2, Eugeni Turkin

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

NDI HUMPHREY NGALA, PHD UNIVERSITY OF YAOUNDE I ENS, DEPT OF GEOGRAPHY TEL: /

NDI HUMPHREY NGALA, PHD UNIVERSITY OF YAOUNDE I ENS, DEPT OF GEOGRAPHY TEL: / NDI HUMPHREY NGALA, PHD UNIVERSITY OF YAOUNDE I ENS, DEPT OF GEOGRAPHY TEL: 677885649/697478641 E-mail: hngalan117@gmail.com PRESENTATION OUTLINE I. Introduction (concept and definition) II. III. IV. Infectious

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 28/02/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and

More information

What can be done against XDR-TB?

What can be done against XDR-TB? What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =

More information

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.

More information

Transmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos

Transmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious

More information

Mortality from cancer of the lung in Serbia

Mortality from cancer of the lung in Serbia JBUON 2013; 18(3): 723-727 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Mortality from cancer of the lung in Serbia M. Ilic 1, H. Vlajinac 2,

More information

Using Data For Decision Making

Using Data For Decision Making Using Data For Decision Making Juliana Víctor-Ahuchogu World Bank Acknowledgment and data sources AIDS in the Commonwealth of Independent States: AIDS 2008 MAP Report: Magomed Nashkhoev & Boris Sergeyev,

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 25/01/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and strains within

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

aids in asia and the pacific

aids in asia and the pacific HIV AIDS AND DEVELOPMENT IN ASIA AND THE PACIFIC a lengthening shadow aids in asia and the pacific World Health Organization Regional Offices for South East Asia and the Western Pacific Region 9 10 OCTOBER

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 30/06/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution

More information

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and

More information

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)

More information

Influenza Global Epidemiologic Update

Influenza Global Epidemiologic Update Influenza Global Epidemiologic Update November 10 th, 2017 1. GLOBAL WHO SUMMARY based on data up to 15 October 2017 North America: Overall influenza virus activity remained low, with detections of predominantly

More information

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13 Cotton Trade Net Exporters Africa Argentina Australia India Other Former Soviet Union Other Latin America Other Middle East Pakistan Turkey United States Uzbekistan Total Net Exports 5.01 5.62 5.62 5.66

More information

Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis

Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis REVIEW 10.1111/j.1469-0691.2011.03577.x Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis W. Sougakoff National Reference Centre for Mycobacteria (CNR-MyRMA), Laboratoire

More information

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11

More information

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11

More information

Childlessness in Europe: Reconstructing long-term trends among women born in

Childlessness in Europe: Reconstructing long-term trends among women born in Childlessness in Europe: Reconstructing long-term trends among women born in 1900-1972 Tomáš Sobotka Vienna Institute of Demography (Austrian Academy of Sciences), Wittgenstein Centre for Demography and

More information

Cross-Border Cooperation in the Global Fight against Communicable Diseases

Cross-Border Cooperation in the Global Fight against Communicable Diseases "Cross-Border Cooperation in the Global Fight against Communicable Diseases," East Asian Regional Cooperation in the Fight Against HIV/AIDS, Tuberculosis, and Malaria; (Beijing Conference, 2006), Tokyo:

More information

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB

More information

UPDATE OF MOLECULAR EPIDEMIOLOGICAL ANALYSIS OF ASFV IN EUROPE

UPDATE OF MOLECULAR EPIDEMIOLOGICAL ANALYSIS OF ASFV IN EUROPE WORKSHOP on Harmonisation of data collection on African Swine Fever (ASF) virus November 23 th 25 th, 2015 EFSA, Parma, Italy UPDATE OF MOLECULAR EPIDEMIOLOGICAL ANALYSIS OF ASFV IN EUROPE Jovita Fernández-Pinero,

More information

HPAI H5(N8) in Member States in poultry, captive and wild birds

HPAI H5(N8) in Member States in poultry, captive and wild birds HPAI H5(N8) in Member States in poultry, captive and wild birds (01/10/2016-01/03/2017) DG Health and Food Safety 13,578,000 5,610,000 234,000 Broad migration flows of ducks across Europe 1,000,000 71,000

More information

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 08/05/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

The Western Pacific Region faces significant

The Western Pacific Region faces significant COMBATING COMMUNICABLE DISEASES A medical technician draws blood for HIV screening in Manila. AFP elimination of mother-to-child transmission of HIV and congenital syphilis was piloted in Malaysia and

More information

A Finer Snapshot of Circulating Mycobacterium tuberculosis Genotypes in Guadeloupe, Martinique, and French Guiana

A Finer Snapshot of Circulating Mycobacterium tuberculosis Genotypes in Guadeloupe, Martinique, and French Guiana JCM Accepts, published online ahead of print on May J. Clin. Microbiol. doi:.8/jcm.78- Copyright, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 6 7 8 9

More information

Influenza Update N 157

Influenza Update N 157 Influenza Update N 157 13 April 2012 Summary In most areas of the northern hemisphere temperate regions, influenza activity appears to have peaked and is declining. In North America, influenza indicators

More information

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza OIE Situation Report for Avian Influenza Latest update: 24/04/2017 This report presents an overview of current disease events reported to the OIE by its Members. The objective is to describe what is happening

More information

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with

More information

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Reflecting on ten years of progress in the fight against AIDS, TB and malaria Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:

More information

Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013

Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013 1 Tuberculosis surveillance in Germany Data of the tuberculosis report 2013 Robert Koch Institute (RKI) Respiratory Infections Unit Outline 2 Tuberculosis notification system in Germany Epidemiological

More information

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Recommended composition of influenza virus vaccines for use in the 2007 influenza season Recommended composition of influenza virus vaccines for use in the 2007 influenza season September 2006 This recommendation relates to the composition of vaccines for the forthcoming winter in the southern

More information

Key Highlights continued

Key Highlights continued Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family

More information

Multidrug-resistant Tuberculosis - World, Europe, Switzerland

Multidrug-resistant Tuberculosis - World, Europe, Switzerland Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results

More information

Drug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye

Drug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case

More information

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs, U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on

More information

Noronet report, April 2013

Noronet report, April 2013 Noronet report, April 2013 Janko van Beek, Annelies Kroneman, Harry Vennema, Marion Koopmans National Institute for Public Health and the Environment, Bilthoven, The Netherlands The major aim of Noronet

More information

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response.

THE BENCHMARK. UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response. THE BENCHMARK UNAIDS and the polling company Zogby International surveyed the world on what people think about the AIDS epidemic and response. THE BENCHMARK UNAIDS and the polling company Zogby International

More information

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada

More information

MARKET NEWS for pig meat

MARKET NEWS for pig meat MARKET NEWS for pig meat Market analysis 17 December 2018 Week 51 MARKET SITUATION Europe: Trading in legs and other cuts is at unchanged or slightly falling prices. UK: Prices are reported as stable.

More information

A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China

A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China A Country-Wide Study of Spoligotype and Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates from Children in China Weiwei Jiao 1., Zhiguang Liu 2,3., Rui Han 1., Xiuqin Zhao 2,3, Fang

More information

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella

More information

MI Flu Focus. Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories

MI Flu Focus. Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories MI Flu Focus Influenza Surveillance Updates Bureaus of Epidemiology and Laboratories Editor: Susan Peters, DVM PetersS1@michigan.gov January 3, 2013 Surveillance and Infectious Disease Epidemiology Vol.

More information

CHAPTER I. CONTENTS.

CHAPTER I. CONTENTS. 199 CHAPTER I. CONTENTS. 200 201 202 THE INCIDENCE OF EPIDEMIC INFLUENZA DURING 1918-19 IN EUROPE AND IN THE WESTERN HEMISPHERE. BY R. BRUCE Low, C.B., M.D. INTRODUCTION. When it was first recognised that

More information

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS). Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),

More information

The epidemiology of tuberculosis

The epidemiology of tuberculosis The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications

More information

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in

More information

California s Experiences Using Tuberculosis Whole Genome Sequencing

California s Experiences Using Tuberculosis Whole Genome Sequencing California s Experiences Using Tuberculosis Whole Genome Sequencing Martin Cilnis MS, MPH Epidemiologist California Department of Public Health, TB Control Branch, Outbreak Prevention and Control Section

More information

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics

Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948

More information

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures Q4 2009 Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures and Unit Prices Executive Summary The WHO, in collaboration with IMS, has put in place a programme

More information

The accident injuries situation

The accident injuries situation Appendix 2. The accident injuries situation Almost 90 % of injury deaths take place in home and leisure Almost 80 % of accidents leading to injury take place in home and leisure Unintentional injuries

More information

GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA

GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA GLOBAL AND REGIONAL SITUATION OF AVIAN INFLUENZA Dr Gounalan Pavade OIE Regional Expert Group Meeting for the Control of Avian Influenza in Asia Sapporo, Japan 3-5 October 2017 1 Avian influenza Outbreaks

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Enterovirus 71 Outbreak in P. R. China, 2008

Enterovirus 71 Outbreak in P. R. China, 2008 JCM Accepts, published online ahead of print on 13 May 2009 J. Clin. Microbiol. doi:10.1128/jcm.00563-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response

Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response Paolo Carlo Belli, Country Sector Coordinator, Human Development ECA Region May 13, 2011 November 28, 2007 ECA AIDS

More information

Genotypic diversity of Mycobacterium tuberculosis in Pretoria

Genotypic diversity of Mycobacterium tuberculosis in Pretoria Genotypic diversity of Mycobacterium tuberculosis in Pretoria P Hove, J Molepo, S Dube, M Nchabeleng Prisca Hove, HBMLS, MSc(Med)Micro, Postgraduate Student Julitha Molepo, NDMedTech, BSc (Hons), MSc,

More information

Selected vaccine introduction status into routine immunization

Selected vaccine introduction status into routine immunization Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF

More information

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015 Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained

More information

The cancer burden in the European Union and the European Region: the current situation and a way forward

The cancer burden in the European Union and the European Region: the current situation and a way forward The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers

More information

GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)

GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) Pr. Olivier Beauchet, MD, PhD Department of Neuroscience Geriatrics Division and Memory Clinic Angers University Hospital and School of

More information

Latest Funding Trends in AIDS Response

Latest Funding Trends in AIDS Response Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July

More information

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Т.Т.Smolskaya 4-5 October 2006 Expert Group on HIV/AIDS for the NDPHS HIV in Russian Federation

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS). Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),

More information

Progress Toward Measles Elimination in the Russian Federation,

Progress Toward Measles Elimination in the Russian Federation, SUPPLEMENT ARTICLE Progress Toward Measles Elimination in the Russian Federation, 2003 2009 G. Onishchenko, 1 E. Ezhlova, 1 A. Gerasimova, 2 O. Tsvirkun, 2 S. Shulga, 2 G. Lipskaya, 3 T. Mamayeva, 2 V.

More information

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation LOGO Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation Irina A.Vasilyeva Chief TB Specialist of the Russian Ministry of Health Central TB Research Institute,

More information

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva

Pandemic H1N Dr. Maria Neira Global Influenza Programme WHO, Geneva Pandemic H1N1 2010 Dr. Maria Neira Global Influenza Programme WHO, Geneva WHO Role during pandemic (H1N1) 2009 Under the International Health Regulations (2005) Detect event (notification by Member States

More information

The Nordic Council of Ministers (NCM) Co-operation with Northwest Russia

The Nordic Council of Ministers (NCM) Co-operation with Northwest Russia The Nordic Council of Ministers (NCM) Co-operation with Northwest Russia Thematic Programme for Health Promotion and Prevention - Mobilizing Resources for Better Response: Immunodeficiency virus and associated

More information